September 11, 2017 / 6:56 AM / in a month

Israel's Teva Pharma appoints H Lundbeck's Kare Schultz as CEO

Sept 11 (Reuters) - Teva Pharmaceutical Industries Ltd named H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, the Israel-based drugmaker said on Monday.

Schultz will succeed Yitzhak Peterburg, who will continue as Teva’s interim CEO until Schultz takes over. (Reporting by Abinaya Vijayaraghavan in Bengaluru)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below